Professional Documents
Culture Documents
BACKGROUND & AIMS: Bacterial infections are a frequent and serious burden among patients with cirrhosis because they can further deteriorate liver function. We assessed
the epidemiology, risk factors, and clinical consequences of
bacterial infections in hospitalized cirrhotic patients. METHODS: In a cohort of hospitalized cirrhotic patients (n 150)
referred to a tertiary care setting, all episodes of bacterial infections
were recorded prospectively. Infections were classified as community-acquired (CA), health careassociated (HCA), or hospital-acquired (HA). Site of infection, characteristics of bacteria, and prevalence of antibiotic resistance were reported; consequences for liver
function and patient survival were evaluated. RESULTS: Fiftyfour infections were observed among 50 patients (12 CA, 22
HCA, and 20 HA). Bacterial resistance was more frequent
among patients with HCA or HA infections (64% of isolates).
Mortality was 37% from HA, 36% from HCA, and 0% from CA
infections. Independent predictors of infection included a previous infection within the past 12 months (P .0001; 95%
confidence interval [CI], 2.210.6), model of end-stage liver
disease score 15 (P .01; 95% CI, 1.3 6.1), and protein
malnutrition (P .04; 95% CI, 1.510). Infectious episodes
worsened liver function in 62% of patients. Patients with infection more frequently developed ascites, hepatic encephalopathy,
hyponatremia, hepatorenal syndrome, or septic shock. Child
class C (P .006; 95% CI, 1.6723.7), sepsis (P .005; 95% CI,
1.721.4), and protein malnutrition (P .001; 95% CI, 2.8
38.5) increased mortality among patients in the hospital.
CONCLUSIONS: In hospitalized cirrhotic patients, the
most frequent infections are HCA and HA; these infections
are frequently resistant to antibiotics. As infections worsen,
liver function deteriorates and mortality increases. Cirrhotic patients should be monitored closely for infections.
Keywords: Sepsis; Survival; Multidrug Resistance; Nutritional
Status.
980
MERLI ET AL
Ethical Committee Review Board, and written informed consent was signed by all the participants.
liver function, development of kidney dysfunction, development of hepatic encephalopathy, gastrointestinal bleeding, ascites, hyponatremia, length of hospital stay, and in-hospital
survival. Patients were re-evaluated as outpatients at 1, 3, and 6
months or until death or liver transplant. The study was closed
when the last patient enrolled had completed at least the
6-month follow-up evaluation.
Definitions
Infections were classified as follows.
Infections were classified as HA if the diagnosis of infection
was made after more than 48 hours of hospital stay.
Infections were classified as HCA if the diagnosis was made
within 48 hours of hospitalization in patients with any of the
following criteria: (1) had attended a hospital or a hemodialysis
clinic, or had received intravenous chemotherapy during the 30
days before infection; or (2) were hospitalized for at least 2 days,
or had undergone surgery during the 180 days before infection;
or (3) had resided in a nursing home or a long-term care
facility.8
Infections were classified as CA if the diagnosis of infection
was made within 48 hours of hospitalization and the patient
did not fulfill the criteria for HCA infection8 (ie, had no recent
contact with the health care system and was not hospitalized in
the past 6 months).
Patients with infections were treated immediately with empiric large-spectrum antibiotics, based on the site of infection
and according to standard guidelines and local epidemiology.
The antibiotic treatment then was modified according to the
results of cultures (if available) and in case of treatment failure.
All patients with infection underwent a consultation by an
infectious diseases specialist with expertise in nosocomial infections.
Patients were considered to have SIRS when they fulfilled the
criteria established by the most recent international guidelines.
Sepsis was diagnosed in the presence of SIRS and a known or
highly suspected infection. Septic shock was defined as sepsis
with hypotension refractory to intravascular volume loading,
associated with perfusion abnormalities that required the use of
inotropes.9
The definition of a multidrug resistant (MDR) pathogen was
used to describe a methicillin-resistant Staphylococcus aureus, an
Acinetobacter baumannii, an extended-spectrum -lactamases
producing gram-negative strain, or any bacterial isolate resistant to at least 3 classes of antimicrobial agents.19,20 Protein
malnutrition was diagnosed when the midarm muscle circumference was below the fifth percentile of the referral standard.13
Statistical Analysis
Each patient was considered only once during the first
hospitalization.
To evaluate liver function modifications induced by the
infection, the tests performed at the time of diagnosis were
compared either with recent previous results (when available) or
with the liver function test at the first outpatient control after
discharge (1 month), when the infection had completely resolved.
All the values are reported as means standard deviations;
P values less than .05 were considered significant. Data were
analyzed as continuous or categoric by using the Student t test
for parametric data and the MannWhitney U test or the Wil-
November 2010
coxon test for nonparametric data; the chi-square test was used
for the comparison of dichotomous data. The logistic regression analysis was used to identify possible predictors of infection and in-hospital mortality. Univariate analysis (log rank)
was used to identify prognostic factors of survival, and the
variables selected by this analysis were included in a multivariate analysis according to a Cox regression model. The software
used for the analysis was NCSS (Number Cruncher Statistical
System, Kaysville, UT) 2007.
Results
Patients
Four patients were excluded, 1 for high-dose steroid
therapy and 3 because of a recurrence of cirrhosis after liver
transplantation. A total of 150 patients was enrolled: 48 women
and 102 men, with a mean age of 64 13 years. The origin of
cirrhosis was hepatitis C in 51% of cases, alcohol abuse in 19%,
cryptogenetic in 15%, autoimmune in 5%, hepatitis B in 4%, and
both hepatitis B and C in 3.3% of patients. Child class was A in
30%, B in 39%, and C in 31% of patients. The mean MELD score
at admission was 13.5 (range, 5 40). The main reasons for
hospital admission were as follows: ascites in 37 patients (25%),
elective procedures in 33 (22%), suspected infection in 21 (14%),
encephalopathy in 20 (13%), gastrointestinal bleeding in 12
(8%), renal failure in 5 (3%), and other reasons in the remaining
22 patients (15%). Forty-nine patients had clinical evidence of
ascites at the time of hospitalization, and 82 were known to
have esophageal varices (48 small and 34 large varices). Fiftytwo patients reported a previous documented infection in the
past 12 months (19 urinary tract infections, 13 pneumonia, 4
spontaneous bacteremia, 4 biliary tract infections, 3 gastrointestinal, 3 skin infections, 2 SBP, and 6 in other sites). Seventeen
patients received antibiotics in the preceding 30 days, 9 because
of a recent infectious episode and 8 because of prophylaxis with
quinolones.
Thirteen patients had been treated previously with transjugular intrahepatic portosystemic shunt. Twenty-six cases had a
diagnosis of hepatocellular carcinoma (HCC), 18 were within the
Milan criteria,21 and 8 exceeded the Milan criteria (3 of these
patients also had portal thrombosis). The 26 patients with HCC
were hospitalized either for diagnostic purposes (3 cases), to receive locoregional treatment (21 cases), or for other complications
of cirrhosis (2 patients).
A total of 54 episodes of bacterial infection were recorded in
50 patients (33%); 4 patients presented more than one episode
of infection during hospitalization. Demographic, clinical, and
biochemical characteristics of the patients with and without
infection are shown in Table 1.
The degree of liver impairment was significantly more severe
in the patients with infection. The patients who developed an
infection had significantly lower albumin levels (P .001),
higher bilirubin levels (P .002), higher creatinine levels (P
.001), and lower sodium levels (P .008) than those who did
not.
981
and spontaneous bacteremia (13%). Table 2 shows the frequency of the different sites of infection in the 3 epidemiologic
groups. Twenty-six infections were documented microbiologically. Gram-negative organisms, particularly Escherichia coli, were
isolated more frequently (62%) than gram-positive ones (38%),
but gram-positive bacteria were prevalent in HA infections (64%
of isolates). Blood cultures were positive in 12 episodes of
infection: 3 urinary infections, 4 cases of cholangitis, 2 cases of
pneumonia, 1 case of SBP, and 2 cases of spontaneous bacteremia.
As shown in Table 2, 16 patients had an infection caused by
MDR bacteria. Six of the 16 patients (37.5%) with MDR pathogens died during their hospital stay (3 HRS, 2 septic shock, 1
variceal bleeding). Among the 17 patients undergoing antibiotic
therapy in the preceding 30 days, MDR pathogens were isolated
more frequently (5 of 7 infectious episodes; P .002).
SIRS was diagnosed in 43 patients and sepsis was diagnosed
in 31 patients. The type of infection more often leading to
sepsis was pneumonia. SIRS unrelated to infection mostly occurred in those patients undergoing invasive treatments.
Clinical Features
A worsening of liver function frequently was observed
in patients with infection, especially in those with sepsis. The
ChildPugh score deteriorated in 62% of cases with infection
(mean increase in Child score, 1.9 0.8; range, 12) and
in 71% of patients with sepsis (mean increase in Child
score, 2.5 0.7; range, 1 4), whereas the MELD score in
the same patients showed a mean increase of 3.8 2.7
(range, 1 4) in patients with infection and of 4.9 2.7
(range, 112) in those with sepsis. The parameters that deteriorated more often were as follows: bilirubin (4.4 12
mg/dL), albumin (0.34 0.9 g/dL), creatinine (0.6
1.8 mg/dL), and serum sodium (3.3 6.1 mEq/L) levels,
respectively. Moreover, episodes of ascites, hepatic encephalopathy, hyponatremia, HRS, and septic shock were more
frequent in patients with infection as compared with those
who were not infected (Table 6).
Outcomes
Overall in-hospital mortality was 12%; 14 patients
with and 4 patients without infection died (28% vs 4%; P
.00007). The mortality rate was higher in the patients with
sepsis (12 of 31; 38%) than in those with infection but no
sepsis (2 of 19, 10%; P .00000).
982
MERLI ET AL
Table 1. Demographic, Clinical, and Biochemical Characteristics of Patients Included in the Study Classified According to the
Presence of Infection During Their Hospitalization
Variables
Age, y
Male/females
Active alcohol abusers, n (%)
Origin of liver disease
Alcohol, n (%)
HCV-related, n (%)
HBV-related, n (%)
Other, n (%)
Main cause of admission
Elective procedure, n (%)
Ascites, n (%)
Suspected infection, n (%)
Encephalopathy, n (%)
Gastrointestinal bleeding, n (%)
Renal failure, n (%)
Other, n (%)
HCC, n (%)
MELD score
ChildPugh score
Mean arterial pressure, mm Hg
Heart rate, beats/min
Respiratory rate, breaths/min
Temperature, 37.5C
White blood cells, cell/mm3
Hemoglobin level, g/dL
Platelets, num/mm3 103
Alanine aminotransferase level, IU/L
Serum bilirubin level, mg/dL
Serum albumin level, mg/dL
International normalized ratio
Serum creatinine level, mg/dL
Blood urea nitrogen level, mg/dL
Serum sodium level, mmol/L
Serum potassium level, mmol/L
Sedimentation rate, mm/h
P value
63 13
64/36
21 (21)
65 13
38/12
14 (28)
.3
.1
.6
19 (19)
56 (56)
6 (6)
19 (19)
10 (20)
21 (42)
5 (10)
14 (28)
.8
.1
.37
.09
31 (31)
30 (30)
0 (0)
11 (11)
9 (9)
2 (2)
17 (17)
20 (20)
11.8 4.5
7.6 2.0
88 11
75 13
15 2
6 (6)
5297 2754
11.6 2.3
120 95
57 62
3.1 5.6
3.3 0.6
1.5 1.3
0.91 0.44
23.2 18.2
135.7 5.1
4.4 0.7
21 19
2 (4)
7 (14)
21 (42)
9 (18)
3 (6)
3 (6)
5 (10)
7 (14)
17.1 7.4
8.7 2.1
84 20
82 14
18 4
37 (74)
9229 5973
10.9 3.6
123 88
58 79
7.6 12.0
2.7 0.7
1.5 0.4
1.57 1.58
37.9 30.5
130.0 19.6
4.2 0.2
37 26
.001
.001
.001
.16
.4
.14
.15
.36
.001
.001
.08
.001
.001
.016
.001
.13
.9
.9
.002
.001
.54
.001
.001
.008
.7
.001
Patient mortality was related to the epidemiology of infection: patients with HA infections, in fact, had a mortality
rate (37%) similar to that of patients with HCA infections
(36%), whereas none of the patients with CA infections died
(P .046).
Univariate analysis showed that sepsis (P .00000), bacterial
infections (P .00002), MELD score of 15 or greater (P .03),
Child class C (P .00004), protein malnutrition (P .000001),
development of antibiotic resistance (P .00009), and hyponatremia (P .002) were related significantly to mortality.
Multivariate analysis selected Child class C (P .006; odds ratio
[OR], 6.3; 95% confidence interval [CI], 1.6723.7), sepsis (P
.0056; OR, 6.01; 95% CI, 1.721.46), and protein malnutrition
(P .0004; OR, 10.44; 95% CI, 2.8 38.5) as independent predictors of in-hospital death. Causes of in-hospital death in
patients with infections were HRS (6 patients), septic shock (5
patients), hemorrhagic shock (2 patients), severe arrhythmia
causing cardiovascular arrest (1 patient). All of the 4 patients
who died without infection died of end-stage liver failure, and
3 of them also had a diagnosis of advanced HCC.
Discussion
Cirrhosis presently may be considered one of the most
common immunodeficiency-acquired conditions and previous
studies reported an infection rate of 40% to 50% among hospitalized cirrhotic patients, with consequent significant morbidity
and mortality rates.2,5 In the present study, we found the following: (1) the large majority of bacterial infections in hospitalized cirrhotic patients are HCA or HA; (2) the high prevalence of these epidemiologic categories contributes to a higher
November 2010
HCA
(n 22)
HA
(n 20)
Previous infections
(past 12 months)
4 (33)
3 (25)
1 (8)
1 (8)
4 (18)
5 (23)
4 (18)
2 (9)
9 (45)
4 (20)
2 (10)
1 (5)
1 (8)
2 (16)
2 (9)
4 (18)
1 (5)
2 (10)
4 (33)
11 (50)
11 (55)
MELD score, 15
Protein malnutrition
0
1
1
1
4
3
1
2
0
9
2
2
2 (16)
9 (41)
5 (23)
983
Infections
Sepsis
OR, 4.7
95% CI, 2.210.6
P .000
OR, 2.8
95% CI, 1.3 6.1
P .001
OR, 4
95% CI, 1.510
P .004
OR, 3.4
95% CI, 1.3 8.1
P .007
OR, 4.4
95% CI, 1.8 10
P .001
OR, 4
95% CI, 1.510
P .004
had a diagnosis of SBP, a rate similar to that reported previously in other Italian studies.3
Enteric gram-negative cocci were the microorganisms more
frequently isolated, whereas gram-positive ones were more frequent in the HA infection group. It has recently been proposed
that antibiotic resistances are increasing in hospitalized cirrhotic patients and this has been attributed to the larger diffusion of quinolone prophylaxis for SBP.6 In the present study we
found a consistent (64%) number of MDR pathogens among
the isolates. This high prevalence was probably related to the
great number of HCA and HA infections that were diagnosed in
our series, because the patients with advanced liver disease
frequently are in need of hospital care. Previous studies, performed on noncirrhotic patients, showed that HA and HCA
infections are caused more frequently by antibiotic-resistant
bacteria and are associated with a more severe clinical course
than CA infections.8,22 A different empiric treatment for this
new epidemiologic category has been suggested. The present
prospective and observational study reports data on HCA infections in cirrhotic patients. We confirm that, as in other
categories, in cirrhotic patients HCA infections also are similar
to HA infections with regard to the prevalence of antibioticresistant pathogens, severe clinical course, and unfavorable outcome (in-hospital mortality in our series was 37% in HCA, 36%
in HA, and none of the patients with CA infections died). In a
recent meta-analysis, only the severity of liver disease has been
Variables
Previous hospitalizations
(past 6 months), n (%)
Previous infections (past
12 months), n (%)
ChildPugh class C, n (%)
MELD score, 15, n (%)
Protein malnutrition, n (%)
Transjugular intrahepatic
portosystemic shunt,
n (%)
Recent gastrointestinal
bleeding (7 d), n (%)
Antibiotic therapy in the
preceding 30 days
Diabetes, n (%)
Patients without
infections
(100)
Patients with
infections
(50)
P
value
37 (37)
33 (66)
.006
Variables
26 (26)
26 (52)
.002
24 (24)
25 (25)
19 (19)
5 (5)
22 (44)
25 (50)
26 (52)
12 (24)
.012
.002
.001
.02
Patients undergoing
invasive procedures,
n (%)
Invasive procedures,
number per patienta
Patients hospitalized in a
room with an
additional bed, n (%)
6 (6)
4 (8)
.64
9 (9)
8 (16)
.2
16 (32)
.8
29 (29)
aInvasive
P
value
66 (74)
14 (75)
.08
1.77 1.1
2.4 1.7
.02
19 (19)
10 (62)
.001
984
MERLI ET AL
Table 6. Clinical Complications in 150 Cirrhotic Patients With and Without Infections and With and Without Sepsis During
Their Hospitalization
Patients with
infection (50)
Patients
without
infection (100)
P value
Patients with
sepsis (31)
Patients without
sepsis (119)
P value
7 (14)
4 (8)
19 (38)
33 (66)
7 (14)
19 (38)
6 (12)
14 (28)
0
2 (2)
15 (15)
51 (51)
6 (6)
14 (14)
0
4 (4)
.001
.05
.0015
.08
.2
.001
.001
.001
5 (16)
4 (13)
11 (35)
23 (74)
5 (16)
13 (42)
6 (19)
12 (38)
2 (1.6)
2 (1.6)
23 (19)
61 (51)
8 (6.7)
8 (6.7)
0
6 (5)
.001
.004
.05
.02
.2
.001
.001
.001
high-risk group may help in planning a different empiric antibiotic approach in this category.
Supplementary Material
Note: To access the supplementary material accompanying this article, visit the online version of Clinical Gastroenterology and Hepatology at www.cghjournal.org, and at doi:10.1016/
j.cgh.2010.06.024.
References
1. Gustot T, Durand F, Lebrec D, et al. Severe sepsis in cirrhosis.
Hepatology 2009;50:20222033.
2. Borzio M, Salerno F, Piantoni L, et al. Bacterial infection in
patients with advanced cirrhosis: a multicentre prospective
study. Dig Liver Dis 2001;33:41 48.
3. Fasolato S, Angeli P, Dallagnese L, et al. Renal failure and
bacterial infection in patients with cirrhosis: epidemiology and
clinical features. Hepatology 2007;45:223229.
4. Wong F, Bernardi M, Balk R, et al. International Ascites Club.
Sepsis in cirrhosis: report on the 7th meeting of the international
ascites club. Gut 2005;54:718 725.
5. Christou L, Pappas G, Falagas ME. Bacterial infection-related
morbidity and mortality in cirrhosis. Am J Gastroenterol 2007;
102:1510 1517.
6. Fernndez J, Navasa M, Gmez J, et al. Bacterial Infection in
cirrhosis: epidemiological changes with invasive procedures and
Norfloxacin prophylaxis. Hepatology 2002;35:140 148.
7. Fernndez J, Ruiz del Arbol L, Gmez C, et al. Norfloxacin vs
ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and haemorrhage. Gastroenterology 2006;131:
1049 1456.
8. Venditti M, Falcone M, Corrao S, et al. Study Group of the Italian
Society of Internal Medicine. Outcomes of patients hospitalized
with community-acquired, health care-associated, and hospitalacquired pneumonia. Ann Intern Med 2009;150:19 26.
9. Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis
and septic shock: 2008. Crit Care Med 2008;36:296 327.
10. Pugh RN, Murray-Lyon IM, Dawson JL, et al. Transection of the
oesophagus for bleeding oesophageal varices. Br J Surg 1973;
60:646 649.
11. Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict
survival in patients with end-stage liver disease. Hepatology
2001;33:464 470.
12. Salerno F, Gerbes A, Gins P, et al. Diagnosis, prevention and
November 2010
13.
14.
15.
16.
17.
18.
19.
20.
21.
985
22. Friedman ND, Kaye KS, Stout JE, et al. Health care associated
bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern
Med 2002;137:791797.
23. Sam J, Nguyen GC. Protein-calorie malnutrition as a prognostic
indicator of mortality among patients hospitalized with cirrhosis
and portal hypertension. Liver Int 2009;29:1396 1402.
24. Merli M, Giusto M, Gentili F, et al. Nutritional status: its influence
on the outcome of patients undergoing liver transplantation. Liver
International 2010;30:208 214.
25. Trautwein C, Boker K, Manns MP. Hepatocyte and immune system: acute phase reaction as a contribution to early defence
mechanism. Gut 1994;35:11631166.
26. Gabay C, Kushner I. Acute-phase proteins and other systemic
responses to inflammation. N Engl J Med 1999;340:448 454.
Reprint requests
Address requests for reprints to: Professor Manuela Merli, MD,
Gastroenterologia II, Dipartimento di Medicina Clinica, Sapienza
Universit di Roma, Viale dellUniversit 37, 00185 Rome, Italy.
e-mail: manuela.merli@uniroma1.it; fax: (39) 064453319.
Acknowledgments
The authors thank Mrs Maria Teresa Barbieri for assistance with the
English revision.
Conicts of interest
The authors disclose no conicts.
Funding
Supported by a research grant C26FO9BMAN from Sapienza University of Rome.
November 2010
Supplementary Figure 1. Survival in 150 hospitalized cirrhotic patients according to the presence of infection. Curves were estimated
using the KaplanMeier method. A period of 6-months follow-up was
examined. Patients with diagnosis of infection at the time of enrollment
showed a higher rate of mortality (P .0001).
985.e1